#106 Five TechBio Myths That Must Go — Guillermo Vela (Co-Founder NeuScience) - a podcast by Mustafa Sultan

Guillermo Vela is the CEO and Co-Founder of NeuScience, a VC-backed TechBio company using AI to discover novel cancer biomarkers.   

0:00 Intro 

0:55 Eroom's Law 

5:37 Contrarian View of Cancer 

15:54 AI Will Not Make Drug Discovery Fast, Better or Cheaper 

26:14 Failing is Not a Good Thing 

26:38 TechBio Funding 

34:07 Habits   

He went viral, in the techbio scene, with his 'Five TechBio Myths That Must Go' article in which he explained why it doesn’t take $2.5bn to develop a drug and why technologies like AI wont’ make drug discovery faster, better or cheaper.  We discuss that article, we discuss Guillermo’s contrarian view of cancer, why we’re doing more science than ever but not seeing results and how his ADD brain is a superpower.  

I hope you enjoy.  

You can find me on Twitter @MustafaSultan and subscribe to my newsletter on www.musty.io

Further episodes of Big Picture Medicine

Further podcasts by Mustafa Sultan

Website of Mustafa Sultan